Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cirrhosis
Interventions
DRUG

standard medical therapy

diuretics, albumin infusion, antibiotics, nutrition, and variceal banding wherever needed

DRUG

G-CSF

G-CSF at the dosage of 5 µg/Kg subcutaneously every 12 hr for five consecutive days then every 3 monthly for 3 days till 1 year

DRUG

Growth Hormone

Growth Hormone in low dose of 1unit sc daily for 1 year

Trial Locations (2)

160012

Dept. of Hepatology, PGIMER, Chandigarh, Chandigarh

Unknown

Department of Hepatology,Postgraduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT02451033 - Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study | Biotech Hunter | Biotech Hunter